Cargando…
Expertenempfehlung: Therapie nichtgehfähiger Patienten mit Muskeldystrophie Duchenne
BACKGROUND: Duchenne muscular dystrophy (DMD) is the most frequent genetic neuromuscular disease in childhood with loss of ambulation usually occurring around the age of 9–11 years. OBJECTIVE, MATERIAL AND METHODS: Based on current guidelines and clinical trials, neuropediatric and neurological expe...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Medizin
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026471/ https://www.ncbi.nlm.nih.gov/pubmed/33215271 http://dx.doi.org/10.1007/s00115-020-01019-3 |